Specialty Rheumatology
-
Featured
First Classification Criteria Developed for IgG4–Related Disease
The American College of Rheumatology and the European League Against Rheumatism that includes Massachusetts General Hospital physicians have developed and validated classification criteria for IgG4–related disease in a large cohort of patients.
-
COVID-19 Patients with Rheumatic and Musculoskeletal Diseases at Substantial Risk of Poor Outcomes
Clinicians in the Division of Rheumatology, Allergy and Immunology found that for patients with rheumatic and musculoskeletal diseases who develop COVID-19, the risks of death and other severe outcomes have declined since early in the pandemic but remain considerable.
-
Data Reveal Risks of COVID-19 mRNA Vaccine Allergic Reactions
New data on vaccinations among employees at Mass General Brigham has alleviated some concern about the safety of mRNA-based COVID-19 vaccines.
-
Prevalence of Anaphylaxis Increasing in U.S. Infants and Toddlers
Massachusetts General Hospital researchers, Lacey B. Robinson, MD, MPH, and Carlos A. Camargo, Jr., MD, DrPH, found that between 2006 and 2015 in the U.S., emergency department visits for anaphylaxis in infants and toddlers more than doubled while hospitalizations declined.
-
Clinical Epidemiology Program Advances Rheumatology Care
Massachusetts General Hospital's Clinical Epidemiology Program utilizes multidisciplinary collaborations, big data and omics sciences to advance rheumatology and COVID-19 care.
-
Case Series: COVID-19 Patients with Rheumatic Disease Can Develop SARS-CoV-2 Antibodies
Kristin M. D'Silva, MD, and Zachary S. Wallace, MD, MSc, of the Rheumatology Unit, report that 10 out of 13 patients (77%) who had a rheumatic disease and COVID-19, and subsequently underwent SARS-CoV-2 antibody testing, had detectable antibodies.
Rheumatology contributors
-
Andrew D. Luster, MD, PhD
Chief of the Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Director of the Center for Immunology and Inflammatory Diseases
Recent Article
The Role of Atypical Chemoattractant Receptors in Recruiting Neutrophils into Inflamed Tissue Sites
-
Hak Soo Choi, PhD
Director, Bioengineering and Nanomedicine Program, Massachusetts General Hospital, Associate Professor of Radiology, Harvard Medical School, Faculty, Dana-Farber/Harvard Cancer Center
Recent Article
Tissue-Specific Contrast Agents for Optical Fluorescence to Evaluate Rheumatoid Arthritis -
John H. Stone, MD, MPH
Director, Clinical Rheumatology, Massachusetts General Hospital, Edward A. Fox Chair in Medicine at Mass General
Recent Article
Transforming Understanding of IGg4-Related Systemic Disease
-
Yuqing Zhang, DSc
Director of Epidemiological and Biostatistical Methods, Rheumatology Unit, Massachusetts General Hospital, Professor in Residence in Medicine, Harvard Medical School
Recent Article
Osteoarthritis of Knee or Hip Increases Risk of Venous Thromboembolism -
Zachary S. Wallace, MD, MSc
Physician, Rheumatology Unit, Massachusetts General Hospital
Recent Article
Case Series: COVID-19 Patients with Rheumatic Disease Can Develop SARS-CoV-2 Antibodies
Rheumatology
The Rheumatology Unit at Massachusetts General Hospital provides leading-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.
